Spontaneous preterm birth due to intrauterine infection is associated with increased concentrations of cytokines in amniotic fluid and in the airways at birth. Intra-amniotic IL-1 induces fetal lung maturity, consistent with the decrease in the incidence of respiratory distress syndrome (RDS) in intrauterine inflammation. On the other hand, antenatal corticosteroid decreases the incidence of RDS in infants born prematurely. The aim of the present study was to investigate the interaction between IL-1 and glucocorticoid in the expression of the surfactant proteins SP-A, -B, and -C. Lung explants from rabbit fetuses at 22 (immature), 27 (transitional), and 30 ( The principal cause of RDS in newborns is surfactant deficiency due to immaturity of type II alveolar cells (1). Lung surfactant prevents atelectasis, contributes toward a decrease in alveolar edema and small airway closure, and is involved in pulmonary host defense. Apart from lipids, the complex contains specific SP that are bound to surfactant aggregates. SP-A is a hydrophilic C-type lectin, whereas SP-B and SP-C are hydrophobic membranous proteins. They all have highly specific roles in surfactant function (2, 3). Antenatal corticosteroid therapy given in the case of imminent premature birth decreases the incidence of RDS and intracranial hemorrhage (4).
Spontaneous preterm birth due to intrauterine infection is associated with increased concentrations of cytokines in amniotic fluid and in the airways at birth. Intra-amniotic IL-1 induces fetal lung maturity, consistent with the decrease in the incidence of respiratory distress syndrome (RDS) in intrauterine inflammation. On the other hand, antenatal corticosteroid decreases the incidence of RDS in infants born prematurely. The aim of the present study was to investigate the interaction between IL-1 and glucocorticoid in the expression of the surfactant proteins SP-A, -B, and -C. Lung explants from rabbit fetuses at 22 The principal cause of RDS in newborns is surfactant deficiency due to immaturity of type II alveolar cells (1) . Lung surfactant prevents atelectasis, contributes toward a decrease in alveolar edema and small airway closure, and is involved in pulmonary host defense. Apart from lipids, the complex contains specific SP that are bound to surfactant aggregates. SP-A is a hydrophilic C-type lectin, whereas SP-B and SP-C are hydrophobic membranous proteins. They all have highly specific roles in surfactant function (2, 3) . Antenatal corticosteroid therapy given in the case of imminent premature birth decreases the incidence of RDS and intracranial hemorrhage (4) .
Glucocorticoids have been shown to influence the expression of SP in the fetal lung (5) . In human fetal lung explants, Dx stimulated the expression of SP-A at low concentrations (Յ10 Ϫ8 M) and after short exposure (24 -48 h) or inhibited the expression of SP-A at higher doses as well as after longer exposure (3-4 d) (6 -8) . The stability of SP-A mRNA decreased acutely after Dx (8, 9) . In explants from rabbit lung, Dx (10 Ϫ7 M) decreased the rate of transcription of SP-A mRNA within 24 h, whereas the transcription rate was increased by Dx within 48 h (10). Both SP-B and SP-C were up-regulated by Dx in explants from mid-trimester human lung (11) (12) (13) and from fetal rabbit during the third trimester (14 -16), whereas SP-C was unaffected in 30-d-old fetal rabbit lung (17) .
Chorioamnionitis is the main setting associated with very premature birth. In this condition, the concentrations of IL-1␣ and IL-1␤ (18) and other cytokines (19) are increased in the amniotic fluid and in the airways shortly after birth (20) . In very premature infants born due to intrauterine infection, the incidence of RDS is lower than could be expected on the basis of their very early birth (21) . Premature infants who were more mature than in the series of Watterberg et al. (21) showed an increased incidence of RDS in intrauterine infection (22) .
When given intra-amniotically to immature rabbit or sheep, IL-1␣ increases SP-A and SP-B mRNA and decreases the severity of RDS after premature birth (23, 24) . As studied in lung explants, IL-1␣ has a biphasic influence on the expression of SP, increasing SP-A and SP-B mRNA in very premature lung and decreasing the expression SP-B and SP-C in transitional and mature lung (25) .
Antenatal glucocorticoid therapy may decrease the incidence of RDS, brain damage, and neonatal death after preterm birth due to intrauterine inflammatory syndrome (4, 26) . In immature lung, both proinflammatory cytokines and the antiinflammatory glucocorticoid influence lung maturity and the differentiation of the surfactant complex. The aim of the present study was to investigate the interactions of a cytokine (IL-1␣) and a glucocorticoid (Dx) in the expression of SP in explants recovered from rabbit lung during the last trimester and the perinatal period. Hysterotomy was performed, and shortly after that, i.v. pentobarbital was given to the doe. The pups were killed by decapitation, and the abdominal aorta was severed. The lungs were recovered under sterile conditions. In addition, 1-d-old newborn rabbits were killed and the lungs were recovered.
MATERIALS AND METHODS

Animal
Recombinant human IL-1␣ (rhIL-1␣) (endotoxin content Ͻ0.01% of dry wt) was a generous gift of Dr. R. Chizzonite (Hoffmann LaRoche, Nutley, NJ, U.S.A.). RhIL-1␣ is biologically active in rabbit (27) . Dx and actinomycin D were purchased from Sigma-Aldrich (Helsinki, Finland).
Organ culture. The organ culture conditions have been described previously (25) . Briefly, in one experiment the lungs recovered from all fetuses from the litter were mixed and cut into cubes (approximately 2 mm 3 each). Five of such pieces were placed on a filter paper that was on a metallic grid in a culture dish. The tissue was maintained in culture for 20 h. Thereafter, IL-1␣, Dx, or vehicle was added and incubation was continued for the next 20 h, unless otherwise indicated. After the culture, lung tissue explants from one culture dish were harvested in a microcentrifuge tube, frozen in liquid nitrogen, and stored at Ϫ70°C, until processed for mRNA analysis.
Analysis of mRNA. RNA was isolated and blotted as described previously (25) . The membranes were hybridized using probes of 1.9 kb rabbit SP-A cDNA, 0.6 kb rabbit SP-B cDNA, or 0.5 kb rabbit SP-C cDNA (23) . The purified inserts were labeled with 32 P using the oligolabeling kit from Amersham Pharmacia Biotech AB (Uppsala, Sweden). To compensate for gel-loading artifacts, the membranes were probed with 32 Pradiolabeled 28S RNA-specific cDNA clone. The bands were quantified using PhosphorImager.
Expression of results and statistics. The mRNA levels of SP-A, SP-B, and SP-C are presented as means Ϯ SEM for convenience. mRNA in the presence of IL-1, Dx, and the combination of IL-1 and Dx is expressed relative to mRNA vehicle-treated controls, respectively. The number of independent mRNA analyses is shown as n. Statistical significance was analyzed using independent samples t test. When indicated, ANOVA followed by post hoc analysis with the Scheffé test was performed. A p value Ͻ 0.05 was considered as significant.
RESULTS
Influence of the agonist on the expression of SP as a function of age. The explants from d 22 and d 30 fetal lung were exposed to Dx (3 ϫ 10 Ϫ9 M-10 Ϫ6 M), IL-1␣ (57 ng/mL or 570 ng/mL), or a combination of Dx (10 Ϫ7 M) and IL-1␣ for 20 h. In immature lung explants from 22 d gestation, SP-A expression was not acutely affected by Dx at any concentration, whereas both concentrations of IL-1␣ up-regulated the expression of SP-A mRNA. Dx at 10 Ϫ7 M increased the effect of IL-1 on the expression of SP-A mRNA additively. At the high concentration of IL-1␣ (570 ng/mL), the additive effect Dx was statistically significant (p ϭ 0.04) (Fig. 1A) . In contrast to SP-A, 10 Ϫ7 M Dx increased SP-B expression 3.5 Ϯ 0.5-fold in immature lung, and the increase in SP-B expression was evident at Dx concentrations ranging from 3 ϫ 10 Ϫ9 M to 10 Ϫ6 M (data not shown). The combined effect of Dx and IL-1␣ on SP-B expression tended to be additive (Fig. 1A) . IL-1 at 57 ng/mL or both Dx and IL-1 (57 ng/mL or 570 ng/mL) had no significant effect on the expression of SP-C in explants from 22-d-old fetal lung; IL-1␣ at 570 ng/mL decreased SP-C mRNA in this setting. Dx at 10 Ϫ7 M (n ϭ 4) had a nonsignificant increasing effect on the expression of SP-C in the test documenting the interaction of Dx and IL-1 (Fig. 1A) . However, concentration studies revealed a 1.6 Ϯ 0.24-fold (p ϭ 0.027) up-regulation of SP-C mRNA by Dx at 10 Ϫ7 M (n ϭ 11).
In 30 d term fetal lung, Dx at 10 Ϫ7 M did not influence the expression of SP-A mRNA, whereas IL-1␣ at 570 ng/mL down-regulated SP-A. This decrease was abolished by Dx (Fig.  1B) . IL-1 suppressed the expression of hydrophobic SP, SP-B, and SP-C by approximately 50% (Fig. 1B) , whereas Dx at 3 ϫ 10 Ϫ9 M, 10 Ϫ7 M, and 10 Ϫ6 M increased the SP-B expression 1.8 Ϯ 0.24 (n ϭ 4, p Ͻ 0.05), 1.6 Ϯ 0.13 (n ϭ 6, p Ͻ 0.05), and 1.4 Ϯ 0.17 (n ϭ 6, p Ͻ 0.05) -fold, respectively. In contrast, SP-C mRNA was unaffected by any concentration of Dx. Similarly to SP-B, Dx reduced or abolished the suppression of SP-C by IL-1␣ (Fig. 1B) .
The effects of Dx (10 Ϫ7 M), IL-1␣ (57 ng/mL), and the combination of Dx and IL-1 on the expression of SP-A, -B, and -C were studied in transitional (27- Stability of mRNA. We studied the stability of SP-A, -B, and -C mRNA in the lung explants from 22-and 27-d-old rabbit fetuses. The content of SP mRNA was studied after the addition of actinomycin D, an inhibitor of mRNA synthesis. After preincubation for 20 h in serum-free Waymouth's media, IL-1 (570 ng/mL), Dx (10 Ϫ7 M), or a combination of IL-1 and Dx was added, or the media was changed for the control explants. Four hours later, actinomycin D (5 or 15 g/mL) was added. The mRNA value at that zero time point, i.e. 4 h after the addition of agonists, was considered to be 100%. The levels of (Fig. 2) . In explants from immature lung, IL-1 and Dx tended to increase the degradation of SP-A mRNA compared with vehicle-treated tissue. However, when added together, these agents tended to stabilize SP-A mRNA. Dx decreased the stability of SP-B mRNA, whereas in the presence of IL-1␣ or IL-1␣ and Dx, mRNA stability was unaffected. In contrast, IL-1␣ decreased the stability of SP-C mRNA, whereas Dx or IL-1␣ and Dx had no detectable effect. In 27-d fetal explants, on the other hand, IL-1 increased the degradation of SP-A, SP-B, and SP-C mRNA. Dx together with IL-1 tended to stabilize SP-B and SP-C mRNA.
DISCUSSION
We report evidence of additive up-regulation of SP-A and SP-B mRNA expression by IL-1␣ and Dx in immature fetal lung in vitro. In contrast, in transitional and mature lung, Dx increased the expression of SP-B and SP-C and abolished the inhibitory effects of IL-1 on these proteins.
The suppression of SP-B and SP-C expression by IL-1 in transitional lung was found to be associated with decreased mRNA stability. Although Dx up-regulated the expression of SP-B, the stability of SP-B mRNA was not increased, suggesting that the increase in mRNA was controlled by the rate of transcription (28) . In immature lung, Dx tended to acutely decrease the stability of SP-B mRNA in contrast to the previously reported increase in SP-B half-life in 21-d fetal rabbit lung after prolonged exposure to steroid (15) . Margana and Boggaram (15) exposed the explants to Dx for 5 d versus 20 h in the present study. Spontaneous differentiation of lung takes place during culture in vitro (29) . This could alter the steroid or cytokine responsiveness. Thus, in explants from immature lung after a prolonged culture period or in explants from transitional lung after a brief period of culture (d 27 in this study), steroid or cytokine responsiveness resembles the responses seen at a more advanced stage of differentiation. The stability of SP-B mRNA in transitional and mature rabbit lung has not been studied previously. No increase in the SP-B transcription rate was evident when lung explants from 26-or 30-d fetal rabbits were exposed to Dx for 48 h (16) . In human mid-trimester lung, the up-regulation of SP-B mRNA was found to be due to an increased rate of gene transcription as well as increased mRNA stability (30) . Any evaluation of the differences between the glucocorticoid and cytokine effects in the different experimental designs is difficult. According to the present results, the Dx-induced acute up-regulation of SP-B expression in very premature as well as in transitional/mature lung is likely to be due to an increase in the transcription rate.
IL-1 (23, 24) or LPS (31, 32) administered intraamniotically to fetal rabbit and sheep accelerates lung maturation by improving respiratory function after premature birth and increasing the expression of SP-A and SP-B. In lamb fetuses, the expression of SP-C was increased as well (33) . Maternal betamethasone also increased SP-A, -B, and -C mRNA (34) and improved lung function in preterm lamb (35) , although less than IL-1 (24) or LPS (32) . When maternal betamethasone treatment was combined with intra-amniotic endotoxin, lung function improved synergistically, even though the effect on the surfactant phospholipid content was not additive (36) . Here, we show that, in immature lung, glucocorticoid and IL-1 increased additively or synergistically the expression of SP-A and SP-B and tended to stabilize the SP-A and SP-B mRNA consistently with the additive effect. The present study further provided evidence indicating that, in explants from more mature lung, Dx decreased the IL-1-induced degradation of SP-B and SP-C mRNA. This seems to explain the finding that Dx restored the mRNA levels of SP-B and SP-C, which were decreased by IL-1␣. Thus, IL-1 and Dx tended to cooperatively stabilize SP-B mRNA regardless of age.
The decreasing effect of LPS (37) and IL-1 (33) on the severity of RDS has been associated with a dose-dependent increase in the pulmonary inflammatory cell response. In the present in vitro setting, however, the effect of IL-1 on the expression of SP-A and SP-B takes place acutely in the absence of inflammatory cell accumulation. This implies that the cytokine-induced recruitment of inflammatory cells and the cytokine induction of SP are independent processes, although they proceed in parallel in vivo.
The present results support the evidence showing that antenatal glucocorticoid prevents RDS in intrauterine inflammation, and that the treatment may be beneficial even close to term (4, 26) . In infants born after 31 wk of gestation, the risk of RDS was significantly higher in preterm premature rupture of fetal membranes than in gestational controls without antenatal steroid prophylaxis (22) . This finding is consistent with experimental evidence (25, 38) . After birth, a strong inflammatory reaction is evident in the airways and alveolar spaces in BPD (39) and in acute RDS (40) . In acute RDS, the levels of SP-B decrease in bronchoalveolar lavage fluid (41) . The steroid-induced acute decrease of respiratory failure in postnatal infants developing BPD is due to multiple, insufficiently characterized effects (42) . Here, we propose that the steroidinduced stability of SP-B and SP-C mRNA increases the translation products that are critical determinants of surfactant function and necessary for alveolar stability. This could contribute toward the decrease in respiratory failure following near-term antenatal (4) or postnatal steroid treatments given in imminent or established BPD (43) .
The present in vitro model allows study of the mechanism of action of different pharmacologic agents on the surfactant system during the perinatal period. This approach has some limitations. The model is not physiologic, i.e. the differentiation takes place spontaneously without added agonists, and it is difficult to relate the dose responsiveness rates of the steroid or cytokine in vitro and in vivo. However, the cytokine-induced expression of SP mRNA has also been shown at the level of SP (25, 38) . In addition, the documented cytokine and glucocorticoid effects in vitro reveal similarities compared with animal experiments demonstrating a decrease in the severity of RDS. More prospective studies are needed to determine the most 
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favorable and safe corticosteroid dosage in imminent premature birth and in severe respiratory failure after birth.
